Your browser doesn't support javascript.
loading
Validation of data quality in the Swedish National Register for Breast Cancer.
Löfgren, Lars; Eloranta, Sandra; Krawiec, Kamilla; Asterkvist, Annette; Lönnqvist, Charlotta; Sandelin, Kerstin.
Afiliação
  • Löfgren L; Department of Surgery, S:t Görans Hospital, SE-11281, Stockholm, Sweden. lars.lofgren@capiostgoran.se.
  • Eloranta S; Scandinavian Development Services, Danderyd, Sweden.
  • Krawiec K; Regional Cancer Centre Stockholm - Gotland, Stockholm, Sweden.
  • Asterkvist A; Regional Cancer Centre Stockholm - Gotland, Stockholm, Sweden.
  • Lönnqvist C; Regional Cancer Centre Stockholm - Gotland, Stockholm, Sweden.
  • Sandelin K; Department of Molecular Medicine and Surgery Karolinska Institutet, Stockholm, Sweden.
BMC Public Health ; 19(1): 495, 2019 May 02.
Article em En | MEDLINE | ID: mdl-31046737
ABSTRACT

BACKGROUND:

The National Breast Cancer Register (NBCR) of Sweden was launched in 2008 and is used for quality assurance, benchmarking, and research. Its three reporting forms encompass Notification, Adjuvant therapy and Follow-up. Target levels are set by national and international guidelines. This national validation assessed data quality of the register.

METHODS:

Data recorded through the Notification form were evaluated for completeness, timeliness, comparability and validity. Completeness was assessed by cross-linkage to the Swedish Cancer Register (SCR). Comparability was analyzed by comparing registration routines in NBCR with national and international guidelines. Timeliness was defined as the difference between the earliest date of diagnosis and the reporting date to NBCR. Validity was assessed by re-abstraction of medical chart data for 800 randomly selected patients diagnosed in 2013.

RESULTS:

The completeness of the NBCR was high with a coverage across regions and years (2010-2014) of 99.9%. Of all incident cases reported to the NBCR in 2013 (N = 8654), 98.5% were included within 12 months and differences between health regions were essentially negligible. Coding procedures followed guidelines and were uniformly adhered to. The proportion of missing values was < 5% for most variables and reported information generally had high exact agreement (> 90%).

CONCLUSIONS:

Completeness of data, comparability and agreement in the NBCR was high. For clinical quality purposes and benchmarking, improved timeliness is warranted. Assessment of validity has resulted in a thorough review of all variables included in the Notification form with clarifications and revision of selected variables.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Controle de Qualidade / Neoplasias da Mama / Sistema de Registros / Confiabilidade dos Dados Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Adult / Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Controle de Qualidade / Neoplasias da Mama / Sistema de Registros / Confiabilidade dos Dados Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Adult / Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article